The University of Chicago Header Logo

Connection

Marina Chiara Garassino to Infusions, Intravenous

Back to Details
This is a "connection" page, showing publications Marina Chiara Garassino has written about Infusions, Intravenous.
Marina Chiara Garassino
Connection Strength
0.036
Infusions, Intravenous
  1. Phase II Trial of Atezolizumab As First-Line or Subsequent Therapy for Patients With Programmed Death-Ligand 1-Selected Advanced Non-Small-Cell Lung Cancer (BIRCH). J Clin Oncol. 2017 Aug 20; 35(24):2781-2789.
    View in: PubMed
    Score: 0.036
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.